Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Marston Linehan

Showing results (311-320 of 487) with videos related to

Pageof 49
Sort By:
Journal of Magnetic Resonance Imaging : JMRI|November 19, 2013
Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathologyBaris Turkbey, Maria J Merino, Elma Carvajal Gallardo, et al.
The Journal of Pathology|November 3, 2025
mTOR-mediated upregulation of B7-H3 in MiT/TFE translocation renal cell carcinomaHuili Li, Adrianna Amaral, Thiago Vidotto, et al.
Urologic Oncology|February 26, 2025
Characterization of metabolic and imaging profiles in the diagnosis of succinate dehydrogenase- related hereditary pheochromocytomas and paragangliomasJessica Y Hsueh, Neil Mendhiratta, Julie Solomon, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2017
Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA DamageBradley T Scroggins, Jeffrey Burkeen, Ayla O White, et al.
Endocrine-Related Cancer|July 20, 2007
Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin BFrederieke M Brouwers, Sven Gläsker, Amanda F Nave, et al.
The Lancet. Oncology|April 14, 2025
Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 studyRamaprasad Srinivasan, Othon Iliopoulos, Kathryn E Beckermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinomaYoun-Soo Lee, Alexander O Vortmeyer, Irina A Lubensky, et al.
Cancer Science|April 9, 2022
Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugateShintaro Funasaki, Sally Mehanna, Wenjuan Ma, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 16, 2008
Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytomaGraeme Eisenhofer, Thanh-Truc Huynh, Abdel Elkahloun, et al.
Urology|December 29, 2011
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancerHari Trivedi, Baris Turkbey, Ardeshir R Rastinehad, et al.
Pageof 49

Showing results (311-320 of 487) with videos related to

Sort By:
Pageof 49
Journal of Magnetic Resonance Imaging : JMRI|November 19, 2013
Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathologyBaris Turkbey, Maria J Merino, Elma Carvajal Gallardo, et al.
The Journal of Pathology|November 3, 2025
mTOR-mediated upregulation of B7-H3 in MiT/TFE translocation renal cell carcinomaHuili Li, Adrianna Amaral, Thiago Vidotto, et al.
Urologic Oncology|February 26, 2025
Characterization of metabolic and imaging profiles in the diagnosis of succinate dehydrogenase- related hereditary pheochromocytomas and paragangliomasJessica Y Hsueh, Neil Mendhiratta, Julie Solomon, et al.
International Journal of Radiation Oncology, Biology, Physics|November 22, 2017
Mithramycin A Enhances Tumor Sensitivity to Mitotic Catastrophe Resulting From DNA DamageBradley T Scroggins, Jeffrey Burkeen, Ayla O White, et al.
Endocrine-Related Cancer|July 20, 2007
Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin BFrederieke M Brouwers, Sven Gläsker, Amanda F Nave, et al.
The Lancet. Oncology|April 14, 2025
Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 studyRamaprasad Srinivasan, Othon Iliopoulos, Kathryn E Beckermann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Coexpression of erythropoietin and erythropoietin receptor in von Hippel-Lindau disease-associated renal cysts and renal cell carcinomaYoun-Soo Lee, Alexander O Vortmeyer, Irina A Lubensky, et al.
Cancer Science|April 9, 2022
Targeting chemoresistance in Xp11.2 translocation renal cell carcinoma using a novel polyamide-chlorambucil conjugateShintaro Funasaki, Sally Mehanna, Wenjuan Ma, et al.
American Journal of Physiology. Endocrinology and Metabolism|October 16, 2008
Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytomaGraeme Eisenhofer, Thanh-Truc Huynh, Abdel Elkahloun, et al.
Urology|December 29, 2011
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancerHari Trivedi, Baris Turkbey, Ardeshir R Rastinehad, et al.
Pageof 49